Motivational Interviewing for encouraging quit attempts among unmotivated smokers: Study protocol of a randomized, controlled, efficacy trial

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Catley, Delwyn ^a   Harris, Kari Jo ^b   Goggin, Kathy ^a   Richter, Kimber ^c   Williams, Karen ^a   Patten, Christi ^d   Resnicow, Ken ^e   Ellerbeck, Edward ^c   Bradley Ewing, Andrea ^a   Malomo, Domonique ^a   Liston, Robin ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF MONTANA   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Brief advice; Health education; Motivational Interviewing; Smoking

Indexed keywords

BENZAZEPINE DERIVATIVE; NICOTINIC RECEPTOR BLOCKING AGENT; QUINOXALINE DERIVATIVE; VARENICLINE;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH EDUCATION; HUMAN; METHODOLOGY; MOTIVATION; MOTIVATIONAL INTERVIEWING; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION;

ADULT; BENZAZEPINES; HEALTH EDUCATION; HUMANS; MOTIVATION; MOTIVATIONAL INTERVIEWING; NICOTINIC ANTAGONISTS; PATIENT SELECTION; QUINOXALINES; SMOKING; SMOKING CESSATION;

EID: 84862278749     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-456     Document Type: Review

References (40)

1. State-specific prevalence of cigarette smoking and smokeless tobacco use among adults - United States, 2009. Centers for Disease Control and Prevention, MMWR Morb Mortal Wkly Rep 2010 59 1400 1406 21048561
2. Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. Centers for Disease Control and Prevention, MMWR Morb Mortal Wkly Rep 2008 57 1226 1228 19008791
3. How long will today's new adolescent smoker be addicted to cigarettes? Pierce JP, Gilpin E, Am J Public Health 1996 86 253 256 10.2105/AJPH.86.2.253 8633747
4. Mortality from cancer in relation to smoking: 50years observations on British doctors. Doll R, Peto R, Boreham J, Sutherland I, Br J Cancer 2005 92 426 429 15668706
5. Cigarette smoking among adults-United States, 2000. Centers for Disease Control and Prevention, MMWR Morb Mortal Wkly Rep 2002 51 642 645 12186222
6. Stages and processes of self-change of smoking: toward an integrative model of change. Prochaska JO, DiClemente CC, J Consult Clin Psychol 1983 51 390 395 6863699
7. An Overview of NAQC. Bailey L, National Network of Tobacco Cessation Quitlines - 2006 Regional Meeting San Diego, CA: Western Region 2006
8. Association of American Medical Colleges, Physician behavior and practice patterns related to smoking cessation: Summay report 2007
9. Primary care provider attitudes are associated with smoking cessation counseling and referral. Meredith LS, Yano EM, Hickey SC, Sherman SE, Med Care 2005 43 929 934 10.1097/01.mlr.0000173566.01877.ac 16116358
10. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Glasgow RE, Vogt TM, Boles SM, Am J Public Health 1999 89 1322 1327 10.2105/AJPH.89.9.1322 10474547
11. Ten things that Motivational Interviewing is not. Miller WR, Rollnick S, Behav Cogn Psychother 2009 37 129 140 10.1017/S1352465809005128 19364414
12. Motivational interviewing for smoking cessation. Lai DT, Cahill K, Qin Y, Tang JL, Cochrane Database Syst Rev 2011 D006936
13. Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Heckman CJ, Egleston BL, Hofmann MT, Tob Control 2010 19 410 416 10.1136/tc.2009.033175 20675688
14. A Meta-Analysis of Motivational Interviewing: Twenty-Five Years of Empirical Studies. Lundahl BW, Kunz C, Brownell C, Tollefson D, Burke BL, Res Social Work Prac 2010 20 137 160 10.1177/1049731509347850
15. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline Rockville, MD: Department of Health and Human Services. Public Health Service 2008
16. A randomized trial of methods to help clinicians learn Motivational Interviewing. Miller WR, Yahne CE, Moyers TB, Martinez J, Pirritano M, J Consult Clin Psychol 2004 72 1050 1062 15612851
17. Motivational Interviewing. Hettema J, Steele J, Miller WR, Annu Rev Clin Psychol 2005 1 91 111 10.1146/annurev.clinpsy.1.102803.143833 17716083
18. The effects of nicotine gum and counseling among African American light smokers: a 2 x 2 factorial design. Ahluwalia JS, Okuyemi K, Nollen N, Choi WS, Kaur H, Pulvers K, Mayo MS, Addiction 2006 101 883 891 10.1111/j.1360-0443.2006. 01461.x 16696632
19. Self-reported smoking status and exhaled carbon monoxide: results from two population-based epidemiologic studies in the North of England. Pearce MS, Hayes L, Chest 2005 128 1233 1238 10.1378/chest.128.3.1233 16162711
20. Using breath carbon monoxide to validate self-reported tobacco smoking in remote Australian Indigenous communities. Maclaren DJ, Conigrave KM, Robertson JA, Ivers RG, Eades S, Clough AR, Popul Health Metr 2010 8 2 10.1186/1478-7954-8-2 20170528
21. Miller WR, Rollnick S, Motivational Interviewing: Preparing people for change New York: Guilford Press 2 2002
22. Motivational interviewing for smoking cessation: a meta-analytic review. Hettema JE, Hendricks PS, J Consult Clin Psychol 2010 78 868 884 21114344
23. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. Eisenberg MJ, Filion KB, Yavin D, Belisle P, Mottillo S, Joseph L, Gervais A, O'Loughlin J, Paradis G, Rinfret S, Pilote L, Cmaj 2008 179 135 144 10.1503/cmaj.070256 18625984
24. Varenicline: the newest agent for smoking cessation. Potts LA, Garwood CL, Am J Health Syst Pharm 2007 64 1381 1384 10.2146/ajhp060428 17592002
25. Smoking cessation: an overview of treatment options with a focus on varenicline. Stack NM, Pharmacotherapy 2007 27 1550 1557 10.1592/phco.27.11.1550 17963463
26. Moyers TB, Martin T, Manuel JK, Miller WR, Ernst D, Motivational Interviewing Treatment Integrity 3.1.1 (MITI 3.1.1) University of New Mexico Center on Alcoholism, Substance Abuse and Addictions (CASAA) 2010
27. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J, Addiction 1995 90 607 614 10.1111/j.1360-0443.1995.tb02199.x 7795497
28. Tobacco use and quit attempts among methadone maintenance clients. Richter KP, Gibson CA, Ahluwalia JS, Schmelzle KH, Am J Public Health 2001 91 296 299 11211643
29. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, Mayo MS, JAMA 2002 288 468 474 10.1001/jama.288.4.468 12132977
30. Cigarette smoking among adults-United States, 2006. Centers for Disease Control and Prevention, MMWR Morb Mortal Wkly Rep 2007 56 1157 1161 17989644
31. Self-efficacy and motivation to quit during participation in a smoking cessation program. Boardman T, Catley D, Mayo MS, Ahluwalia JS, Int J Behav Med 2005 12 266 272 10.1207/s15327558ijbm1204-7 16262545
32. Measures of abstinence in clinical trials: issues and recommendations. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE, Nicotine Tob Res 2003 5 13 25 12745503
33. Biochemical verification of tobacco use and cessation. Benowitz NL, Nicotine Tob Res 2002 4 149 159 10.1080/14622200210123581 12028847
34. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Cooke F, Bullen C, Whittaker R, McRobbie H, Chen MH, Walker N, Nicotine Tob Res 2008 10 607 612 10.1080/14622200801978680 18418783
35. Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors. Levesque CS, Williams GC, Elliot D, Pickering MA, Bodenhamer B, Finley PJ, Health Educ Res 2007 22 691 702 17138613
36. Facilitating autonomous motivation for smoking cessation. Williams GC, Gagne M, Ryan RM, Deci EL, Health Psychol 2002 21 40 50 11846344
37. Testing a self-determination theory intervention for motivating tobacco cessation: supporting autonomy and competence in a clinical trial. Williams GC, McGregor HA, Sharp D, Levesque C, Kouides RW, Ryan RM, Deci EL, Health Psychol 2006 25 91 101 16448302
38. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Baron RM, Kenny DA, J Pers Soc Psychol 1986 51 1173 1182 3806354
39. A comparison of methods to test mediation and other intervening variable effects. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V, Psychol Methods 2002 7 83 104 11928892
40. Asymptotic confidence intervals for indirect effects in structural equation models. Sobel ME, Sociological Methodology Washington DC: American Sociological Association, Leinhardt S, 1982 290 312